Predicting treatment response to intra-arterial therapies for hepatocellular carcinoma with the use of supervised machine learning—an artificial intelligence concept
Purpose To use magnetic resonance (MR) imaging and clinical patient data to create an
artificial intelligence (AI) framework for the prediction of therapeutic outcomes of transarterial …
artificial intelligence (AI) framework for the prediction of therapeutic outcomes of transarterial …
Optimization of the BCLC staging system for locoregional therapy for hepatocellular carcinoma by using quantitative tumor burden imaging biomarkers at MRI
Background Patients with intermediate-and advanced-stage hepatocellular carcinoma
(HCC) represent a highly heterogeneous patient collective with substantial differences in …
(HCC) represent a highly heterogeneous patient collective with substantial differences in …
[HTML][HTML] Post locoregional therapy treatment imaging in hepatocellular carcinoma patients: a literature-based review
S Young, AJ Taylor, T Sanghvi - Journal of Clinical and …, 2018 - ncbi.nlm.nih.gov
Imaging plays a crucial role in the diagnosis of hepatocellular carcinoma (HCC) as well as in
determining treatment efficacy, or complications, following therapy. Unlike other cancers …
determining treatment efficacy, or complications, following therapy. Unlike other cancers …
Comparison of existing response criteria in patients with hepatocellular carcinoma treated with transarterial chemoembolization using a 3D quantitative approach
V Tacher, MD Lin, R Duran, H Yarmohammadi, H Lee… - Radiology, 2016 - pubs.rsna.org
Purpose To compare currently available non–three-dimensional methods (Response
Evaluation Criteria in Solid Tumors [RECIST], European Association for Study of the Liver …
Evaluation Criteria in Solid Tumors [RECIST], European Association for Study of the Liver …
Imaging biomarkers of tumor response in neuroendocrine liver metastases treated with transarterial chemoembolization: can enhancing tumor burden of the whole …
S Sahu, R Schernthaner, R Ardon, J Chapiro, Y Zhao… - Radiology, 2017 - pubs.rsna.org
Purpose To investigate whether whole-liver enhancing tumor burden [ETB] can serve as an
imaging biomarker and help predict survival better than World Health Organization (WHO) …
imaging biomarker and help predict survival better than World Health Organization (WHO) …
Prediction of overall survival in patients with hepatocellular carcinoma treated with Y-90 radioembolization by imaging response criteria
M Ghosn, H Derbel, R Kharrat, N Oubaya… - Diagnostic and …, 2021 - Elsevier
Purpose To evaluate the potential of imaging criteria in predicting overall survival of patients
with hepatocellular carcinoma (HCC) after a first transcatheter arterial yttrium-90 …
with hepatocellular carcinoma (HCC) after a first transcatheter arterial yttrium-90 …
Intra-arterial therapies for liver cancer: assessing tumor response
YW Stroehl, BS Letzen, JMM van Breugel… - Expert Review of …, 2017 - Taylor & Francis
ABSTRACT Introduction: Intra-arterial therapies (IATs) play an integral role in the
management of unresectable hepatocellular carcinoma and liver metastases. The ability to …
management of unresectable hepatocellular carcinoma and liver metastases. The ability to …
Lipiodol as an intra-procedural imaging biomarker for liver tumor response to transarterial chemoembolization: Post-hoc analysis of a prospective clinical trial
BS Letzen, R Malpani, M Miszczuk, QMB de Ruiter… - Clinical imaging, 2021 - Elsevier
Background The use of the ethiodized oil-Lipiodol in conventional trans-arterial
chemoembolization (cTACE) ensures radiopacity to visualize drug delivery in the process of …
chemoembolization (cTACE) ensures radiopacity to visualize drug delivery in the process of …
Predictive modeling for voxel-based quantification of imaging-based subtypes of pancreatic ductal adenocarcinoma (PDAC): a multi-institutional study
Simple Summary Previously, we demonstrated that qualitative scoring of pancreatic ductal
adenocarcinoma (PDAC) tumors on computed tomography (CT) scans (delta) is biologically …
adenocarcinoma (PDAC) tumors on computed tomography (CT) scans (delta) is biologically …
3D Quantitative tumour burden analysis in patients with hepatocellular carcinoma before TACE: comparing single-lesion vs. multi-lesion imaging biomarkers as …
FN Fleckenstein, RE Schernthaner, R Duran… - European …, 2016 - Springer
Objectives To compare the ability of single-vs. multi-lesion assessment on baseline MRI
using 1D-and 3D-based measurements to predict overall survival (OS) in patients with …
using 1D-and 3D-based measurements to predict overall survival (OS) in patients with …